Found: 50
Select item for more details and to access through your institution.
Significant Publications on Infectious Diseases Pharmacotherapy in 2021.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 1, p. 198, doi. 10.1177/08971900221128334
- By:
- Publication type:
- Article
Significant Publications on Infectious Diseases Pharmacotherapy in 2020.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 394, doi. 10.1177/08971900211040438
- By:
- Publication type:
- Article
Significant Publications on Infectious Diseases Pharmacotherapy in 2019.
- Published in:
- Journal of Pharmacy Practice, 2021, v. 34, n. 5, p. 800, doi. 10.1177/0897190020951348
- By:
- Publication type:
- Article
Significant Publications on Infectious Diseases Pharmacotherapy in 2018.
- Published in:
- Journal of Pharmacy Practice, 2019, v. 32, n. 5, p. 546, doi. 10.1177/0897190019863921
- By:
- Publication type:
- Article
Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae341
- By:
- Publication type:
- Article
Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 3, p. 1, doi. 10.1093/ofid/ofad090
- By:
- Publication type:
- Article
Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 10, p. 1, doi. 10.1093/ofid/ofab419
- By:
- Publication type:
- Article
Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab365
- By:
- Publication type:
- Article
Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab286
- By:
- Publication type:
- Article
Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 11, p. 1, doi. 10.1093/ofid/ofaa476
- By:
- Publication type:
- Article
Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz552
- By:
- Publication type:
- Article
LB7. A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S995, doi. 10.1093/ofid/ofz415.2490
- By:
- Publication type:
- Article
688. In Vitro Activity of Eravacycline, a New Tetracycline Analog, and Comparators Against the Six Most Commonly Isolated Ribotypes of Clostridioides difficile.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S312, doi. 10.1093/ofid/ofz360.756
- By:
- Publication type:
- Article
2580. Serial Microbiome Analysis in a Patient with Multiple Failed Fecal Microbiome Transplantations.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S896, doi. 10.1093/ofid/ofz360.2258
- By:
- Publication type:
- Article
2581. An Invertebrate Model to Study Gut Microbiome Dysbiosis.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S896, doi. 10.1093/ofid/ofz360.2259
- By:
- Publication type:
- Article
2402. Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S829, doi. 10.1093/ofid/ofz360.2080
- By:
- Publication type:
- Article
2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S828, doi. 10.1093/ofid/ofz360.2076
- By:
- Publication type:
- Article
2391. Increased Risk of Systemic Infections with Multidrug-Resistant Organisms in Patients with Severe Clostridioides difficile Infection.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S825, doi. 10.1093/ofid/ofz360.2069
- By:
- Publication type:
- Article
2378. Corticosteroid Use Prevents Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use Among Hospitalized Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S820, doi. 10.1093/ofid/ofz360.2056
- By:
- Publication type:
- Article
840. Clinical Failure Rates Associated with Hemin-induced Metronidazole Resistance in Clostridioides difficile.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S11, doi. 10.1093/ofid/ofz359.025
- By:
- Publication type:
- Article
Epidemic Clostridioides difficile Ribotype 027 Lineages: Comparisons of Texas Versus Worldwide Strains.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 2, p. N.PAG, doi. 10.1093/ofid/ofz013
- By:
- Publication type:
- Article
Antibiotic Therapies for Clostridioides difficile Infection in Children.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, p. S52, doi. 10.1093/jpids/piab059
- By:
- Publication type:
- Article
The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an Example.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 9, p. 1441, doi. 10.3390/antibiotics12091441
- By:
- Publication type:
- Article
Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile : A Systematic Review.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 2, p. 258, doi. 10.3390/antibiotics11020258
- By:
- Publication type:
- Article
Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2022, v. 41, n. 10, p. 1207, doi. 10.1007/s10096-022-04473-w
- By:
- Publication type:
- Article
Emerging Options for the Prevention and Management of Clostridioides difficile Infection.
- Published in:
- Drugs, 2023, v. 83, n. 2, p. 105, doi. 10.1007/s40265-022-01832-x
- By:
- Publication type:
- Article
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39429-x
- By:
- Publication type:
- Article
Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2253570, doi. 10.1001/jamanetworkopen.2022.53570
- By:
- Publication type:
- Article
Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of Clostridioides difficile infection in adults.
- Published in:
- SAGE Open Medicine, 2024, p. 1, doi. 10.1177/20503121241274192
- By:
- Publication type:
- Article
Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2022, v. 11, n. 10, p. 454, doi. 10.1093/jpids/piac059
- By:
- Publication type:
- Article
Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 12, p. 2142, doi. 10.1093/cid/ciab826
- By:
- Publication type:
- Article
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. 755, doi. 10.1093/cid/ciab718
- By:
- Publication type:
- Article
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. e1029, doi. 10.1093/cid/ciab549
- By:
- Publication type:
- Article
Toxin A–Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2628, doi. 10.1093/cid/ciz727
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 11, p. 1887, doi. 10.1093/cid/ciy782
- By:
- Publication type:
- Article
Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 10, p. 3303, doi. 10.1007/s10620-020-06683-8
- By:
- Publication type:
- Article
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 1, p. 1, doi. 10.1093/jacamr/dlac131
- By:
- Publication type:
- Article
Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00456-9
- By:
- Publication type:
- Article
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 1, p. 15, doi. 10.1093/cid/ciae087
- By:
- Publication type:
- Article
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S487, doi. 10.1093/cid/ciad642
- By:
- Publication type:
- Article
Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Higher In Vivo Fecal Concentrations of Clostridioides difficile Toxins A and B in Patients With North American Pulsed-Field Gel Electrophoresis Type 1/Ribotype 027 Strain Infection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 11, p. 2019, doi. 10.1093/cid/ciac406
- By:
- Publication type:
- Article
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 7, p. 1164, doi. 10.1093/cid/ciac096
- By:
- Publication type:
- Article
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 6, p. 466, doi. 10.1002/phar.2804
- By:
- Publication type:
- Article
Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin.
- Published in:
- Pharmacoepidemiology (2813-0618), 2023, v. 2, n. 4, p. 283, doi. 10.3390/pharma2040024
- By:
- Publication type:
- Article
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 1, p. 273, doi. 10.1093/infdis/jiad537
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects.
- Published in:
- 2020
- By:
- Publication type:
- journal article
In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Utilizing antibiotics to prevent Clostridioides difficile infection: does exposure to a risk factor decrease risk? A systematic review.
- Published in:
- 2020
- By:
- Publication type:
- journal article